Published in J Fam Plann Reprod Health Care on September 27, 2013
Lidocaine for Pain Control During Intrauterine Device Insertion | NCT03362905
Pain Relief During IUD Insertion in Women Delivered Only by Elective Cesarean Section | NCT03587077
Comment on 'practical advice for avoidance of pain associated with insertion of intrauterine contraceptives'. J Fam Plann Reprod Health Care (2014) 1.54
Comment on 'Practical advice for avoidance of pain associated with insertion of intrauterine contraceptives': authors' response. J Fam Plann Reprod Health Care (2014) 1.40
Comment on 'practical advice for avoidance of pain associated with insertion of intrauterine contraceptives'. J Fam Plann Reprod Health Care (2014) 0.99
Objective Assessment of Cervical Stiffness after Administration of Misoprostol for Intrauterine Contraceptive Insertion. Ultrasound Int Open (2016) 0.75
Comment on 'practical advice for avoidance of pain associated with insertion of intrauterine contraceptives': authors' response. J Fam Plann Reprod Health Care (2014) 0.75
Contraceptive failure in the United States. Contraception (2011) 6.23
Effectiveness of long-acting reversible contraception. N Engl J Med (2012) 5.45
Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women. Contraception (2010) 2.63
Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol (2012) 2.55
Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Hum Reprod (2010) 1.74
Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol (2006) 1.25
Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev (2009) 1.24
Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod (2007) 1.23
Use of the levonorgestrel releasing-intrauterine system in nulliparous women--a non-interventional study in Sweden. Eur J Contracept Reprod Health Care (2011) 1.12
Comparative study of safety and efficacy of IUD insertions by physicians and nursing personnel in Brazil. Bull Pan Am Health Organ (1995) 1.12
Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas. Contraception (2011) 1.09
Cervical priming with misoprostol prior to transcervical procedures. Int J Gynaecol Obstet (2007) 1.08
Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system. Contraception (2010) 1.07
Experience of IUD/IUS insertions and clinical performance in nulliparous women--a pilot study. Eur J Contracept Reprod Health Care (2008) 1.07
Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena). Pharmacoepidemiol Drug Saf (2003) 1.06
A Latin American experience with levonorgestrel IUD. Ann Med (1993) 0.99
Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception (2012) 0.99
Use and effectiveness of oral analgesia when fitting an intrauterine device. J Fam Plann Reprod Health Care (2003) 0.99
Effect of mifepristone on dilatation of the pregnant and non-pregnant cervix. Lancet (1990) 0.97
Management of pain associated with the insertion of intrauterine contraceptives. Hum Reprod Update (2013) 0.96
Cervical lidocaine for IUD insertional pain: a randomized controlled trial. Am J Obstet Gynecol (2012) 0.93
Severe pain at interval IUD insertion: a case-control analysis of patient risk factors. Contraception (1986) 0.93
Efficacy of contraceptive methods: A review of the literature. Eur J Contracept Reprod Health Care (2010) 2.92
Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA (2003) 2.90
Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet (2002) 2.86
Nurse training and the need for IUD fitters to have expertise in resuscitation. J Fam Plann Reprod Health Care (2010) 2.64
Recommendations for standardization of data collection and analysis of bleeding in combined hormone contraceptive trials. Contraception (2006) 2.32
Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial. Obstet Gynecol (2013) 2.26
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism. J Fam Plann Reprod Health Care (2013) 2.07
Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause. Menopause (2014) 2.07
Labor induction versus expectant management for postterm pregnancies: a systematic review with meta-analysis. Obstet Gynecol (2003) 2.05
Embracing post-fertilisation methods of family planning: a call to action. J Fam Plann Reprod Health Care (2013) 2.04
Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. Contraception (2006) 1.90
Misoprostol and the debate over off-label drug use. BJOG (2005) 1.79
Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials. Obstet Gynecol (2005) 1.73
U.S. Food and Drug Administration's Guidance Regarding Morcellation of Leiomyomas: Well-Intentioned, But Is It Harmful for Women? Obstet Gynecol (2016) 1.70
The oncogenic potential of endometrial polyps: a systematic review and meta-analysis. Obstet Gynecol (2010) 1.66
Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. J Immunol (2012) 1.65
Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptives. Contraception (2004) 1.62
Emergency contraception and fertility awareness among university students in Kampala, Uganda. Afr Health Sci (2006) 1.59
Randomized trial to compare perioperative outcomes of Filshie clip vs. Pomeroy technique for postpartum and intraoperative cesarean tubal sterilization: a pilot study. Contraception (2004) 1.57
Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients: a meta-analysis. Obstet Gynecol (2009) 1.53
Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study. Menopause (2014) 1.50
Sonographic cervical assessment to predict the success of labor induction: a systematic review with metaanalysis. Am J Obstet Gynecol (2007) 1.49
HIV/AIDS data in South Africa. Lancet (2002) 1.39
The CHOICE study: effect of counselling on the selection of combined hormonal contraceptive methods in 11 countries. Eur J Contracept Reprod Health Care (2012) 1.19
Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel. Contraception (2009) 1.16
Combined hormonal contraceptive trials: variable data collection and bleeding assessment methodologies influence study outcomes and physician perception. Contraception (2006) 1.14
Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model. Hum Reprod (2007) 1.11
Wingless (Wnt)-3A induces trophoblast migration and matrix metalloproteinase-2 secretion through canonical Wnt signaling and protein kinase B/AKT activation. Endocrinology (2009) 1.09
Comments on two subdermal implant articles. J Fam Plann Reprod Health Care (2011) 1.08
Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system. Contraception (2010) 1.07
Pitfalls of research linking the intrauterine device to pelvic inflammatory disease. Obstet Gynecol (2013) 1.05
Depot medroxyprogesterone acetate and bone mineral density in adolescents--the Black Box Warning: a Position Paper of the Society for Adolescent Medicine. J Adolesc Health (2006) 1.05
Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials. Menopause (2013) 1.05
HLA-DR+ leukocytes acquire CD1 antigens in embryonic and fetal human skin and contain functional antigen-presenting cells. J Exp Med (2009) 1.05
Expectant management versus labor induction for suspected fetal macrosomia: a systematic review. Obstet Gynecol (2002) 1.04
Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy. Menopause (2009) 1.00
Update on hormonal contraception and bone density. Rev Endocr Metab Disord (2011) 1.00
Tolerability and clinical safety of Implanon. Eur J Contracept Reprod Health Care (2008) 0.99
Effect of emergency contraception with levonorgestrel or mifepristone on ovarian function. Contraception (2004) 0.99
WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy. BJOG (2003) 0.99
Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model. Fertil Steril (2008) 0.98
Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril (2008) 0.98
Acceptability of home-use of misoprostol in medical abortion. Contraception (2004) 0.95
Verifying the effectiveness of medical abortion; ultrasound versus hCG testing. Eur J Obstet Gynecol Reprod Biol (2003) 0.95
Use of contraceptive methods and contraceptive recommendations among health care providers actively involved in contraceptive counseling -- results of an international survey in 10 countries. Contraception (2012) 0.94
Maternal death caused by midgut volvulus after bariatric surgery. Am J Obstet Gynecol (2005) 0.94
Labor induction with 25 microg versus 50 microg intravaginal misoprostol: a systematic review. Obstet Gynecol (2002) 0.93
Depo-Provera and skeletal health: a survey of Florida obstetrics and gynecologist physicians. Contraception (2008) 0.93
Regional differences in surgical intervention following medical termination of pregnancy provided by telemedicine. Acta Obstet Gynecol Scand (2011) 0.93
Macrophage-derived IL-33 is a critical factor for placental growth. J Immunol (2013) 0.93
An evidence-based approach to postpartum use of depot medroxyprogesterone acetate in breastfeeding women. Contraception (2009) 0.92
Location and removal of non-palpable Implanon implants with the aid of ultrasound guidance. J Fam Plann Reprod Health Care (2006) 0.91
WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. BJOG (2004) 0.91
Barriers and facilitators in the provision of post-abortion care at district level in central Uganda - a qualitative study focusing on task sharing between physicians and midwives. BMC Health Serv Res (2014) 0.91
Use of and attitudes towards emergency contraception: a survey of women in five European countries. Eur J Contracept Reprod Health Care (2014) 0.91
Do mechanical methods of cervical ripening increase infectious morbidity? A systematic review. Am J Obstet Gynecol (2008) 0.91
Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH). Acta Obstet Gynecol Scand (2007) 0.90
High rates of HIV seropositivity in Africa--alternative explanation. Int J STD AIDS (2003) 0.90
Notch signaling plays a critical role in motility and differentiation of human first-trimester cytotrophoblasts. Endocrinology (2013) 0.89
Effects of ovarian stimulation on endometrial integrin beta3 and leukemia inhibitory factor expression in the peri-implantation phase. Fertil Steril (2007) 0.89
Transcription factor AP-2α promotes EGF-dependent invasion of human trophoblast. Endocrinology (2011) 0.89
Simplified follow-up after medical abortion using a low-sensitivity urinary pregnancy test and a pictorial instruction sheet in Rajasthan, India--study protocol and intervention adaptation of a randomised control trial. BMC Womens Health (2014) 0.89
Global voices on HIV/AIDS. Heterosexual transmission of HIV in Africa is no higher than anywhere else. BMJ (2002) 0.89
Why the product labeling for low-dose vaginal estrogen should be changed. Menopause (2014) 0.88
Diagnostic accuracy of transvaginal sonography for the diagnosis of adenomyosis: systematic review and metaanalysis. Am J Obstet Gynecol (2009) 0.88
Age-related changes in expression and function of Toll-like receptors in human skin. Development (2012) 0.88
Phenotypic characterization of leukocytes in prenatal human dermis. J Invest Dermatol (2012) 0.88
Fertility after discontinuation of contraception: a comprehensive review of the literature. Contraception (2011) 0.88
Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone. Eur J Obstet Gynecol Reprod Biol (2005) 0.88
Downregulation of cilia-localized Il-6R alpha by 17beta-estradiol in mouse and human fallopian tubes. Am J Physiol Cell Physiol (2009) 0.87
Medical students' knowledge, attitudes and perceptions towards contraceptive use and counselling: a cross-sectional survey in Maharashtra, India. BMJ Open (2013) 0.87
Clinical manifestations of rotavirus infection in the neonatal intensive care unit. Pediatr Infect Dis J (2002) 0.86
Progesterone receptor isoform B in the human fallopian tube and endometrium following mifepristone. Contraception (2003) 0.86
Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy. Obstet Gynecol (2013) 0.86
Endometrial receptivity and human embryo implantation. Am J Reprod Immunol (2011) 0.85
The influence of early cleavage on embryo developmental potential and IVF/ICSI outcome. J Assist Reprod Genet (2009) 0.85
Knowledge, attitudes and prescribing pattern of emergency contraceptives by health care workers in Kampala, Uganda. Acta Obstet Gynecol Scand (2007) 0.85
Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis. Obstet Gynecol (2005) 0.85
Clomiphene citrate causes aberrant tubal apoptosis and estrogen receptor activation in rat fallopian tube: implications for tubal ectopic pregnancy. Biol Reprod (2009) 0.84
Assessment of significant factors affecting acceptability of home administration of misoprostol for medical abortion. Contraception (2011) 0.84
Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS). Acta Obstet Gynecol Scand (2011) 0.84
Wnt-dependent T-cell factor-4 controls human etravillous trophoblast motility. Endocrinology (2014) 0.84
Teaching medical students gynaecological examination using professional patients-evaluation of students' skills and feelings. Med Teach (2005) 0.84
Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions. Fertil Steril (2002) 0.84
Sublingual misoprostol for labor induction: a randomized clinical trial. Obstet Gynecol (2005) 0.83
Incidental diagnosis of appendiceal mucocele with vaginal ultrasonography and computed tomography. Obstet Gynecol (2011) 0.83
Contraceptive choice for young people. J Fam Plann Reprod Health Care (2009) 0.83
Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture. Obstet Gynecol (2013) 0.83
Aquaporin 1 is expressed in the human endometrium during normal cycle and increases after mifepristone treatment. Int J Mol Med (2008) 0.82
Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies. Contraception (2012) 0.82
Evaluation of human first trimester decidual and telomerase-transformed endometrial stromal cells as model systems of in vitro decidualization. Reprod Biol Endocrinol (2011) 0.82
A collaborative clinic between contraception and sexual health services and an adult congenital heart disease clinic. J Fam Plann Reprod Health Care (2007) 0.82
Faced with a double-edged risk: Ugandan university students' perception of the emergency contraceptive pill in Uganda. Afr J Reprod Health (2009) 0.82
The protein-to-creatinine ratio for the prediction of significant proteinuria in patients at risk for preeclampsia: a meta-analysis. Ann Clin Lab Sci (2013) 0.81
Reason for the increasing use of vacuum extraction in Sweden: a population-based study. Acta Obstet Gynecol Scand (2013) 0.81
Recent advances in understanding endometrial receptivity: molecular basis and clinical applications. Am J Reprod Immunol (2014) 0.81
Endometriosis and autoimmune disease: association of susceptibility to moderate/severe endometriosis with CCL21 and HLA-DRB1. Fertil Steril (2010) 0.81